|
|
|
|
The Promise Behind Incyte
Biotech investors should have Incyte (INCY) on their radar.Heres why: The drug discovery company will likely be announcing the results of a mid-stage study for an oral rheumatoid arthritis drug in April and analysts are pretty bullish on its prospects. The...
|
|
|
TechMARK movers: Aveva boosted by broker upgrade
LONDON (ShareCast) - Engineering design software provider Aveva is rising on the back of yesterdays upgrade by broker Panmure Gordon.The broker has not touched the forecast for the year to March 2010 but it has increased its 2010-11 earnings per share...
|
|
|
Whitfield battling cancer
Actor Andy Whitfield attends the Cinema Society & John And Aileen Crowley screening of 'Extraordinary Measures' at the School of Visual Arts Theater on Janu Whitfield battling cancer.
|
|
|
Whitfield battling cancer
Actor Andy Whitfield attends the Cinema Society & John And Aileen Crowley screening of 'Extraordinary Measures' at the School of Visual Arts Theater on Janu Whitfield battling cancer.
|
|
|
Whitfield battling cancer
Actor Andy Whitfield attends the Cinema Society & John And Aileen Crowley screening of 'Extraordinary Measures' at the School of Visual Arts Theater on Janu Whitfield battling cancer.
|
|
|
Whitfield battling cancer
Actor Andy Whitfield attends the Cinema Society & John And Aileen Crowley screening of 'Extraordinary Measures' at the School of Visual Arts Theater on Janu Whitfield battling cancer.
|
|
|
Whitfield battling cancer
Actor Andy Whitfield attends the Cinema Society & John And Aileen Crowley screening of 'Extraordinary Measures' at the School of Visual Arts Theater on Janu Whitfield battling cancer.
|
|
|
SafeGuard World International LLC Appoints Pat Goepel as Non-Executive Chairman
SafeGuard World International LLC (SGWI) a leading provider of global and multi-country payroll outsourcing solutions, announces that Pat Goepel has been appointed as Non Executive Chairman for the US business of SGWI.Goepel has had a long standing career...
|
|
|
Rheumatoid Arthritis: Research from Pfizer Inc. provide new insights into rheumatoid arthritis
Today's Medical & Research News Rheumatoid Arthritis Research from Pfizer Inc.provide new insights into rheumatoid arthritis March 4th, 2010 Printer-Friendly Version City:Ann Arbor State:Michigan Country:United States Drugs Enzymes Kinase Methotrexate...
|
|
|
Janus flap: Bilateral nasoseptal flaps for anterior skull base reconstruction
Nyquist GG et al.Janus flap: Bilateral nasoseptal flaps for anterior skull base reconstruction.
|
|
|
Phase Forward to Participate in Key Industry Events in March
Phase Forward (PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events this month including DIAs 22nd Annual EuroMeeting, the DIA/FDA CDER/CBER Computational Science Annual Meeting,...
|
|
|
Phase Forward to Participate in Key Industry Events in March
- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events this month including , the , the and the.At DIA's EuroMeeting, to be held March 8-10 in Monaco, Vice...
|
|
|
Phase Forward to Participate in Key Industry Events in March
WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events this month including DIAs 22nd Annual EuroMeeting, the DIA/FDA CDER/CBER...
|
|
|
Phase Forward to Participate in Key Industry Events in March
Companies mentioned in this article: Phase Forward WALTHAM, Mass.-- (BUSINESS WIRE) -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events this month...
|
|
|
Phase Forward to Participate in Key Industry Events in March
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events this month including DIAs 22 nd Annual EuroMeeting : , the DIA/FDA CDER/CBER Computational Science Annual...
|
|
|
Phase Forward to Participate in Key Industry Events in March
WALTHAM, Mass.--(BUSINESS WIRE)-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events this month including DIA's 22nd Annual EuroMeeting, the , the World CRO...
|
|
|
Phase Forward to Participate in Key Industry Events in March
WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events this month including , the , the and the.At DIA?s EuroMeeting, to be...
|
|
|
New enzyme research study results reported from Johnson & Johnson
New enzyme research study results reported from Johnson & Johnson According to recent research from the United States, 'We have previously shown that Janus kinase 3, a member of the family of non-receptor protein tyrosine kinases, plays a critical...
|
|
|
Enzyme Research: New enzyme research study results reported from Johnson & Johnson
Today's Medical & Research News Enzyme Research New enzyme research study results reported from February 12th, 2010 Printer-Friendly Version City:Spring House State:PA Country:United States Enzyme Research Biochemical Biophysics Enzymes Kinase Proteins...
|
|
|
YM BioSciences announces result of Cytopia shareholder vote
MISSISSAUGA, ON, Jan.12 /PRNewswire-FirstCall/ -- YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM) today announced that YM BioSciences' previously announced proposal to acquire all the shares of Australian biopharmaceutical company, Cytopia Ltd., under a...
|
